is glp 1 safe for kidney disease Glucagon-like peptide-1 receptor agonists in diabetic disease: A review of their kidney and heart protection Recommendations for SGLT2i versus GLP-1

Weight loss drugs have surged in popularity in recent years, transforming the pharmaceutical landscape

GLP-1 medications such as Ozempic and Wegovy have significantly reshaped the weight loss market by improving blood sugar regulation, insulin sensitivity, and appetite control

Growth hormone (GH) is an essential regulator of growth, body composition and fuel metabolism and, consequently, GH secretion is under the feedback control of numerous nutritional and endocrine mediators

Medicines based on glucagon-like peptide-1 (GLP-1) have revolutionized the treatment of diabetes and obesity

Learn common reasons for stalled results and practical tips to restart progress with diet, activity, and clinical guidance.

Is the era of weight loss injections coming to an end